What is Haemochromatosis?
Hereditary haemochromatosis is a genetic disorder of iron metabolism characterized by excessive iron absorption from the gastrointestinal tract, leading to progressive iron accumulation in organs—particularly the liver, heart, and pancreas—which if untreated causes life-threatening complications including cirrhosis, hepatocellular cancer, diabetes, and cardiomyopathy. 1, 2
The Genetic Basis
The disease is caused by mutations in the HFE gene located on chromosome 6. The primary mutation is C282Y, where tyrosine substitutes for cysteine at position 282 of the HFE protein 1. A second mutation, H63D, can act as a cofactor but rarely causes disease alone 1.
Key Genetic Patterns:
- C282Y homozygosity (both chromosomes affected): Found in over 90% of clinically recognized haemochromatosis patients 1
- Compound heterozygosity (C282Y/H63D): Accounts for 3-5% of cases, typically requires additional risk factors like alcohol or fatty liver to manifest disease 1, 3
- H63D homozygosity alone: Generally insufficient to cause haemochromatosis 3
The disease follows an autosomal recessive inheritance pattern 2.
Disease Progression
Haemochromatosis evolves through distinct stages 1:
- Ages 0-20 years: Clinically insignificant iron accumulation (0-5 g stored)
- Ages 20-40 years: Iron overload without organ damage (10-20 g stored)
- Beyond 40 years: Iron overload with organ damage (>20 g stored)
Critical clinical point: Survival is normal when treatment begins before cirrhosis or diabetes develops, making early diagnosis paramount 1.
Major Complications and Mortality
The degree of iron overload directly impacts life expectancy. Major causes of death occur at 10- to 119-fold higher rates than age-matched populations without haemochromatosis 1:
- Decompensated cirrhosis
- Hepatocellular carcinoma
- Diabetes mellitus
- Cardiomyopathy
Prevalence in Ireland
Ireland has the highest prevalence of haemochromatosis in the world, making this particularly relevant to Irish populations 4, 5, 6.
Specific Irish Data:
- C282Y allele frequency in Ireland: 12.5% (compared to 0% in Southern Europe) 4
- Genetic risk in Northwest Ireland: 1 in 54-62 individuals carry the major risk genotype 5
- Overall Irish population: Approximately 1% of Irish newborns are C282Y homozygous (1 in 100) 6
- C282Y allele frequency: 11% in the Irish population 6
- H63D allele frequency: 15% in the Irish population 6
For context, the general Caucasian population has a C282Y homozygosity rate of approximately 1 in 250-260 4, 1, making the Irish rate 2.5 times higher than other Northern European populations.
Geographic Variation Within the British Isles:
Recent data shows marked regional differences 5:
- Highest risk: Northwest Irish and Outer Hebrides (1/54-62)
- Mainland Scotland: 1/117
- Southern England: 1/212 (lowest risk)
White Irish individuals in NHS England have 3.7 times higher prevalence of clinically diagnosed haemochromatosis compared to white British individuals 5.
Why Ireland?
The concentration in populations of Celtic ancestry reflects the disease's origins 1. The C282Y mutation likely arose in Celtic populations and spread through Northern Europe, with Ireland maintaining the highest carrier rates due to genetic founder effects and relative population isolation.
Clinical Recognition
Important caveat: Despite high genetic prevalence, only 58-70% of C282Y homozygotes develop clinically significant iron overload 1, 7. This incomplete penetrance means genetic risk doesn't always translate to disease, though the reasons remain unclear and may involve interactions with other genes or environmental factors.
The disease is increasingly recognized in asymptomatic individuals through routine blood testing rather than classic "bronze diabetes" presentation 7. Currently, approximately 75% of identified patients are asymptomatic at diagnosis 7.